Lisata Therapeutics (LSTA) Stock: Buy, Sell, or Hold?
LSTA - Lisata Therapeutics, Inc. Common Stock
$1.47
-0.02 (-1.34%)
âŧ
5d:
-6.96%
30d:
-6.37%
90d:
-56.12%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When LSTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: LSTA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: LSTA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: LSTA is currently trading at $1.47, which is considered slightly low relative to its 30-day fair value range of $1.47 to $1.73.
Technical Outlook: Technically, LSTA is in a strong downtrend. Immediate support is located at $1.40, while resistance sits at $1.65.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.00 (+172.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LSTA is in a strong downtrend. Immediate support is located at $1.40, while resistance sits at $1.65.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.00 (+172.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.47 -
$1.73
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 172.1% below Wall St target ($4.00)
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.47 -
$1.73
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.40
Resistance Level
$1.65
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.27
Wall Street Target
$4.00
(+172.1%)
Revenue Growth (YoY)
-90.0%
Share & Embed Analysis
Last updated: October 04, 2026 12:35 PM ET
Data refreshes hourly during market hours. Next update: 1:35 PM
Data refreshes hourly during market hours. Next update: 1:35 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LSTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
23 analysts |
$139 | 55 HOLD |
|
DNTH
Dianthus Therapeutics InâĻ |
STRONG BUY
16 analysts |
$141 | 63 BUY |
|
SYRE
Spyre Therapeutics Inc. |
STRONG BUY
17 analysts |
$120 | 56 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 40 SELL |
|
ORKA
Oruka Therapeutics, Inc. |
STRONG BUY
13 analysts |
$155 | 64 BUY |
